|
|
Volumn 202, Issue 2, 2002, Pages 78-83
|
|
Evaluation of an advisory program in antibiotic therapy
a
|
|
Author keywords
Antibiotic policy; Assessment; Costs; Diabetic foot; Eductional programs; Fluoroquinolonas; Infections disease specialist; Sequential therapy
|
|
Indexed keywords
AMINOGLYCOSIDE;
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPICILLIN;
ANTIBIOTIC AGENT;
BETA LACTAMASE INHIBITOR;
CARBAPENEM DERIVATIVE;
CEFAZOLIN;
CEFEPIME;
CEFUROXIME;
CEPHALOSPORIN DERIVATIVE;
CIPROFLOXACIN;
CLARITHROMYCIN;
CLINDAMYCIN;
CLOXACILLIN;
GLYCOPEPTIDE;
MEROPENEM;
METICILLIN;
METRONIDAZOLE;
PENICILLIN DERIVATIVE;
PIPERACILLIN PLUS TAZOBACTAM;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
VANCOMYCIN;
ANTIINFECTIVE AGENT;
ANTIBIOTIC THERAPY;
ARTICLE;
CLOSTRIDIUM DIFFICILE;
CONTROLLED STUDY;
DRUG COST;
DRUG USE;
DRUG WITHDRAWAL;
EVALUATION;
HEALTH CARE PERSONNEL;
HEALTH CARE PLANNING;
HEALTH PROGRAM;
HOSPITAL ADMISSION;
HOSPITAL DEPARTMENT;
HOSPITAL INFECTION;
HUMAN;
INCIDENCE;
INFECTION;
MAJOR CLINICAL STUDY;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MORTALITY;
TREATMENT OUTCOME;
COUNSELING;
HEALTH CARE QUALITY;
INTERVENTION STUDY;
PRESCRIPTION;
STATISTICS;
ANTI-BACTERIAL AGENTS;
COUNSELING;
INTERVENTION STUDIES;
PRESCRIPTIONS, DRUG;
PROGRAM EVALUATION;
|
|
EID: 0035984834
PISSN: 00142565
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-2565(02)70989-2 Document Type: Article |
|
Times cited : (24)
|
|
References (29)
|
